Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with t(14;18)-bearing follicular non-Hodgkin's lymphoma: An exploratory study in 8 patients
M. Debled et al., Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with t(14;18)-bearing follicular non-Hodgkin's lymphoma: An exploratory study in 8 patients, INT J CANC, 84(6), 1999, pp. 558-561
Detection of residual disease in follicular lymphoma is hampered by the obs
ervation of t(14;18)-bearing cells in the blood of healthy adult humans, To
overcome this problem, we decided to validate a quantification method of t
(14;18)bearing cells and test it in t(14;18)-bearing follicular lymphomas (
FL), We designed a competitive PCR method to quantify t(14;18)-bearing cell
s in peripheral blood. First, we controlled overall reliability (specificit
y, sensitivity, reproducibility, precision and accuracy); then we used our
method to study 16 peripheral blood samples collected in 8 patients with t(
14;18)bearing FL. There were considerable variations in the number of circu
lating tumor cell (CTC) in FL patients, ranging from zero to 17,813 cells/m
l. In 2 patients who were sampled before and after treatment and who attain
ed complete remission (CR), a significant decrease in the number of CTC was
observed. In 3 patients with detectable CTC during CR, relapse occurred 4
to 11 months later. Of 3 patients with no detectable CTC, 2 remain in CR 35
and 95 months later, but one relapsed 11 months after sample collection. T
hese preliminary results suggest that quantification of CTC may be worthwhi
le in follicular lymphoma. It may improve our ability to predict relapse oc
currence, but also may help in understanding this peculiar disease. Int. J,
Cancer (Pred. Oncol.) 84:558-561, 1999. (C) 1999 Wiley-Liss, Inc.